Global COVID-19 Drug Delivery Devices Market, By Product Type (Prefilled Syringe, Needle-Free Injectors, Inhalers, Patch), Route of Administration (Parenteral, Nasal, Dermal), End Users (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
COVID-19 drug delivery devices market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 4033.72 million by 2028 from USD 2309.40 million in 2020 and will grow at a CAGR of 7.22% in the above mentioned forecast period.
Drug delivery refers to various formulations, approaches, technologies, and systems for transporting a pharmaceutical compound in the body to achieve its preferred therapeutic effect securely. COVID-19 drug delivery devices are the type of specific tools for delivering a drug or therapeutic agent through a specific route of administration and some machines are used as part of one or more treatments.
There has been a significant surge in efforts by major industry players to speed up the expansion of a novel drug that is proficient of treating the virus, owing to the lack of an adequate vaccine or treatment, which is highly impacting the growth of the COVID-19 drug delivery devices market in line to this, the unavailability of sufficient medications and the lack of effective alternatives for COVID-19 management is also contributing to rising in the global market over the forecast period of 2021 to 2028. Also the continuous attempts are being made to embrace the best vaccines to address the emergency needs triggered by this pandemic which is also enhancing the growth of the market. Likewise, the rising disposable incomes which allow individuals the option to from advanced options for effective treatment thereby lifting the market growth in the above mentioned forecast period. However, the huge cost of R&D will restrict the growth of the COVID-19 drug delivery devices market growth rate.
The rising investments by private and government organizations to increase the accessibility of sufficient countermeasures along with increasing activities in the field of R&D for suitable medical devices will further accelerate the expansion of the COVID-19 drug delivery devices market and are also are offering significant growth opportunities for the market in the forecast period of 2021 to 2028.
This COVID-19 drug delivery devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on COVID-19 drug delivery devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global COVID-19 Drug Delivery Devices Market Scope and Market Size
COVID-19 drug delivery devices market is segmented on the basis of product type, route of administration and end users. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product type, the COVID-19 drug delivery devices market is segmented into prefilled syringe, needle-free injectors, inhalers and patch.
- Based on route of administration, the COVID-19 drug delivery devices market is segmented into parenteral, nasal and dermal.
- The end user segment of the COVID-19 drug delivery devices market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.
COVID-19 Drug Delivery Devices Market Country Level Analysis
COVID-19 drug delivery devices market is analyzed and market size insights and trends are provided by country, product type, route of administration and end users as referenced above.
The countries covered in the COVID-19 drug delivery devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the COVID-19 drug delivery devices market owing to the well-established healthcare infrastructure and presence of large number of key pharmaceutical companies within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the large population base, exponential registered cases of COVID-19 and rapid growth in research funding in this particular region.
The country section of the COVID-19 drug delivery devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
COVID-19 drug delivery devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for COVID-19 drug delivery devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the COVID-19 drug delivery devices market. The data is available for historic period 2010 to 2019.
Competitive Landscape and COVID-19 Drug Delivery Devices Market Share Analysis
COVID-19 drug delivery devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to COVID-19 drug delivery devices market.
The major players covered in the COVID-19 drug delivery devices market report are AstraZeneca, Johnson & Johnson Services, Inc., Serum Institute of India Pvt. Ltd., GlaxoSmithKline plc, Moderna, Inc., Bharat Biotech, Pfizer Inc., PharmaJet, Phillips-Medisize, Panasonic India, Propeller Health, Qualcomm Technologies, Inc., Aterica Inc., West Pharmaceutical Services, Inc., and Novawax, Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.